Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoid-resistant asthma. T-lymphocyte defects

C J Corrigan1

  • 1Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United Kingdom.

American Journal of Respiratory and Critical Care Medicine
|August 1, 1996
PubMed
Summary

Glucocorticoid resistance in asthma is partly due to T cells resisting these drugs. Identifying resistance mechanisms could guide alternative therapies for patients with glucocorticoid-resistant (GR) asthma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021
Same author

Erratum: Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

NPJ primary care respiratory medicine·2019
Same author

Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer.

Journal of biological regulators and homeostatic agents·2018
Same author

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE.

Allergy·2018
Same author

Dendritic cell phenotype in severe asthma reflects clinical responsiveness to glucocorticoids.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Cigarette smoking increases bronchial mucosal IL-17A expression in asthmatics, which acts in concert with environmental aeroallergens to engender neutrophilic inflammation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Clinical glucocorticoid resistance in asthma is a significant challenge.
  • T-cell resistance to glucocorticoid inhibition contributes to this clinical issue.

Purpose of the Study:

  • To explore the role of T-cell resistance in glucocorticoid-resistant (GR) asthma.
  • To suggest potential strategies for alternative therapies in GR asthma.

Main Methods:

  • The study reviews existing evidence on glucocorticoid resistance in asthma.
  • It focuses on the immunological mechanisms involving T cells.

Main Results:

  • T-cell resistance to glucocorticoids is a key factor in GR asthma.
  • Current clinical practices may not expose GR asthma patients to sufficient glucocorticoid doses to inhibit T cells in vivo.

Conclusions:

  • Understanding the mechanisms of T-cell resistance is crucial for developing rational alternative therapies.
  • Assessing other T-cell-inhibiting drugs for efficacy and safety in GR asthma patients is warranted.

Related Experiment Videos